F8 and hemophilia: It shows similar endogenous FVIII activities (median, 5%- 7%), a nonsignificant downward trend in the proportion of patients with moderate hemophilia with increasing age (from 53.5% to 8.7%; P = .52) and a similar number of EDs to FVIII before inhibitor development (median, 34-45 EDs).